Skip to Content
Merck
  • Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor.

Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor.

Chemistry & biology (2005-03-31)
Justin C Yarrow, Go Totsukawa, Guillaume T Charras, Timothy J Mitchison
ABSTRACT

Small-molecule kinase inhibitors are predominantly discovered in pure protein assays. We have discovered an inhibitor of Rho-kinase (ROCK) through an image-based, high-throughput screen of cell monolayer wound healing. Using automated microscopy, we screened a library of approximately 16,000 compounds finding many that affected cell migration or cell morphology as well as compounds that blocked mitotic progression. We tested approximately 200 compounds in a series of subassays and chose one, 3-(4-pyridyl)indole (Rockout), for more detailed characterization. Rockout inhibits blebbing and causes dissolution of actin stress fibers, phenocopying Rho-kinase inhibitors. Testing Rho-kinase activity in vitro, Rockout inhibits with an IC50 of 25 microM ( approximately 5-fold less potent than Y-27632) but has a similar specificity profile. We also profile the wound healing assay with a library of compounds with known bioactivities, revealing multiple pathways involved in the biology.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-α-Actinin antibody produced in mouse, clone BM-75.2, ascites fluid
Sigma-Aldrich
Monoclonal Anti-Ezrin antibody produced in mouse, clone 3C12, ascites fluid
Sigma-Aldrich
Monoclonal Anti-Vinculin antibody produced in mouse, clone hVIN-1, ascites fluid
Sigma-Aldrich
Anti-Phosphotyrosine Antibody, recombinant clone 4G10®, biotin conjugate, clone 4G10®, Upstate®, from mouse